Comparing Arzerra vs Ibrutinib
| Arzerra Remove Arzerra from your drug comparison | Ibrutinib Remove Ibrutinib from your drug comparison |
|---|
| Arzerra ofatumumab Remove Arzerra from your drug comparison | Ibrutinib Remove Ibrutinib from your drug comparison | ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescribed for Chronic Lymphocytic Leukemia. Arzerra may also be used for purposes not listed in this medication guide. |
Prescribed for Chronic Lymphocytic Leukemia, Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma, Lymphoma, Graft-versus-host disease. ibrutinib may also be used for purposes... View more |
|
|||||||
|
Prescription only |
Prescription only |
||||||||
Ratings & ReviewsRecent helpful reviews |
|||||||||
|
N/A |
6.4
For Chronic Lymphocytic Leukemia: Side effects for me: muscle spasms, mouth ulcers, diarrhea, fatigued, dizziness, itchy skin, sore throat, cramps, insomnia, sun sensitivity, and drowsiness. |
||||||||
Drug Class |
|||||||||
Side Effects |
|||||||||
|
See the full Arzerra side effects document. |
Commonly reported side effects include: infection, anemia, neutropenia, thrombocytopenia, bruise, and cytopenia. See the full ibrutinib side effects document. |
||||||||
Pricing and Coupons* Prices are without insurance |
|||||||||
View all Arzerra prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Generic Availability |
|||||||||
|
No |
No |
||||||||
Dosage Form(s) Available |
|||||||||
|
N/A | ||||||||
Brand Names |
|||||||||
| Other ofatumumab brands include: Kesimpta | Imbruvica | ||||||||
Half LifeThe half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. |
|||||||||
|
1476 hours |
6 hours |
||||||||
CSA Schedule**View glossary of terms. |
|||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category |
|||||||||
|
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category D
Positive evidence of risk
See the full Pregnancy Warnings document. |
||||||||
FDA Alerts |
|||||||||
|
N/A |
|||||||||
Drug Interactions |
|||||||||
|
A total of 113 drugs are known to interact with Arzerra:
|
A total of 368 drugs are known to interact with ibrutinib:
|
||||||||
Alcohol/Food/Lifestyle Interactions |
|||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
Disease Interactions |
|||||||||
First Approval Date |
|||||||||
|
N/A |
November 13, 2013 |
||||||||
WADA ClassView World Anti-Doping Agency classifications. |
|||||||||
|
N/A |
N/A |
||||||||
More Information |
|||||||||
Consumer Resources |
|||||||||
Professional Resources |
|||||||||
Related Treatment Guide |
|||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
For Chronic Lymphocytic Leukemia: Started treatment at VA in Houston about 6 weeks ago....lymph nodes back to normal in 1st 2-1/2 weeks. 5th week of treatment started feeling flu like symptoms....got worse over next 2 weeks. Visited with Hematologist a few days ago.....dropped from 3 pills daily to one pill daily. I bounced back in one day.....lots of energy and no more body aches/pain. Night and day difference in a very short time span.